Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 1
2021 2
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

3 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean olshevski v[au] (1 results)?
Mutational landscape of high-grade B-cell lymphoma with MYC-, BCL2 and/or BCL6 rearrangements characterized by whole-exome sequencing.
Künstner A, Witte HM, Riedl J, Bernard V, Stölting S, Merz H, Olschewski V, Peter W, Ketzer J, Busch Y, Trojok P, Bubnoff NV, Busch H, Feller AC, Gebauer N. Künstner A, et al. Among authors: olschewski v. Haematologica. 2022 Aug 1;107(8):1850-1863. doi: 10.3324/haematol.2021.279631. Haematologica. 2022. PMID: 34788985 Free PMC article.
Exhaustion of tumour-infiltrating T-cell receptor repertoire diversity is an age-dependent indicator of immunological fitness independently predictive of clinical outcome in Burkitt lymphoma.
Rieken J, Bernard V, Witte HM, Peter W, Merz H, Olschewski V, Hertel L, Lehnert H, Biersack H, von Bubnoff N, Feller AC, Gebauer N. Rieken J, et al. Among authors: olschewski v. Br J Haematol. 2021 Apr;193(1):138-149. doi: 10.1111/bjh.17083. Epub 2020 Sep 18. Br J Haematol. 2021. PMID: 32945554 Free article.
Systemic Inflammation and Tumour-Infiltrating T-Cell Receptor Repertoire Diversity Are Predictive of Clinical Outcome in High-Grade B-Cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements.
Olschewski V, Witte HM, Bernard V, Steinestel K, Peter W, Merz H, Rieken J, Biersack H, von Bubnoff N, Feller AC, Gebauer N. Olschewski V, et al. Cancers (Basel). 2021 Feb 20;13(4):887. doi: 10.3390/cancers13040887. Cancers (Basel). 2021. PMID: 33672644 Free PMC article.